Companion Medical InPen

The FDA recently approved the smart insulin pen, which is designed to be paired with an Apple iOS app. A first in the U.S., the InPen, which can be re-used for up to one year and works with Humalog or Novalog insulin cartridges, uses Bluetooth to deliver digitized data and, perhaps most important, user convenience.

Diabetes Research Connection – The Idea Factory – Powered By You

Beyond Type 1 is proud to patner with Diabetes Research Connection to accelerate novel research designed to prevent and cure type 1 diabetes, minimize its complications and improve the quality of life for those living with the disease.

Is a New Transplant Site the Key to a Type 1 Cure?

Scientists believe that there may be a better location for cell replacement therapy: the omentum, a layer of fatty tissue that covers the organs in the lower abdomen. Like the liver, it's close to the surface and is also highly vascularized.

Omnipod Now Available to Medicare Part D Patients

Insulet Corporation who makes the Omnipod® pump, a tubeless insulin delivery device, has just been approved by the Centers for Medicare and Medicaid Services (CMS) to be available under the Medicare Part D (prescription drug) program.

FreeStyle Libre System Available to Medicare Patients

Today, Abbott announced that the new, factory-calibrated technology is now available to Medicare patients since its approval by the U.S. Centers for Medicare & Medicaid Services (CMS). It will be the only CGM system available to Medicare patients that doesn't require calibration.

Disrupting D-Tech: Amin Zayani

Beyond Type 1 caught up with MedAngel founder and Lyfebulb 2017 Winner Amin Zayani, who is working to change the way we think about managing diabetes every day.

Temporary Tattoos and Device Help Children Take Insulin Injections

Thomy is an insulin kit that helps children inject insulin. Both fun and innovative, it includes temporary tattoos with planetary designs to mark used injection sites.

GiveTide x Beyond Type 1

The app that lets you round up on purchases and donate to Beyond Type 1 without skipping a beat!

But YOU inspired US

If you ask any member of Team Bike Beyond why they wanted to join the team, you’ll probably get 20 different answers. And there is a good chance that you would get 20 different reasons as to why they kept getting in the saddle day after day, during the ride.

Derek Theler: Diabetes Warrior

The Marvel’s New Warriors actor is the face of Dexcom’s Call of the Warrior campaign, launching this month. Derek spoke to Beyond Type 1 about what it means to be a superhero — both on set and while managing diabetes.

In Depth with Medtronic’s Chief Patient Officer

There’s so much innovative technology, new services, and better education and training. It’s all going to be integrated with your life, in the car, on your body, in the house, with your family, and even with your doctor.

Grant Helps ViaCyte Pursue T1D Cure

The California Institute for Regenerative Medicine (CIRM) awarded ViaCyte a $20 million dollar grant to continue its cutting-edge research towards finding a functional cure for T1D.

The Power of Community

When we face a diabetes diagnosis, one of the best ways to cope with it is by recognizing that the diabetes online community (DOC) is eager and willing to be there for you.

Switching from an Animas Pump – Know Your Options

Here are the insulin pumps available on the market in the United States and their defining features to help you chose the best fit for you or your loved one.

Fast-acting Insulin, Fiasp, Gets FDA Approval

Last Friday the U.S. Food and Drug Administration approved Novo Nordisk’s latest fast-acting insulin, Fiasp, for treatment use by adults with diabetes.